- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-12-mer
- Ligands
- 12 x OJC: (2R,3R,3aS,5S,6R,7S,8R,11R,13S,15aR)-2-(6-amino-9H-purin-9-yl)-3,6,7,11,13-pentahydroxyoctahydro-2H,5H,11H,13H-5,8-epoxy-11lambda~5~,13lambda~5~-furo[2,3-g][1,3,5,9,2,4]tetraoxadiphosphacyclotetradecine-11,13-dione(Non-covalent)
- 12 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
NAD.2: 9 residues within 4Å:- Chain A: A.32, G.33, M.36, S.37, T.114, G.198, F.199, S.200, Y.269
10 PLIP interactions:10 interactions with chain A- Hydrogen bonds: A:A.32, A:G.33, A:T.114, A:F.199, A:S.200, A:S.200, A:S.200, A:Y.269
- pi-Stacking: A:Y.269, A:Y.269
NAD.4: 9 residues within 4Å:- Chain B: A.32, G.33, M.36, S.37, T.114, G.198, F.199, S.200, Y.269
9 PLIP interactions:9 interactions with chain B- Hydrogen bonds: B:A.32, B:G.33, B:T.114, B:G.198, B:F.199, B:S.200, B:S.200
- pi-Stacking: B:Y.269, B:Y.269
NAD.6: 9 residues within 4Å:- Chain C: A.32, G.33, M.36, S.37, T.114, G.198, F.199, S.200, Y.269
9 PLIP interactions:9 interactions with chain C- Hydrogen bonds: C:A.32, C:G.33, C:T.114, C:G.198, C:F.199, C:S.200, C:S.200
- pi-Stacking: C:Y.269, C:Y.269
NAD.8: 9 residues within 4Å:- Chain D: A.32, G.33, M.36, S.37, T.114, G.198, F.199, S.200, Y.269
10 PLIP interactions:10 interactions with chain D- Hydrogen bonds: D:A.32, D:G.33, D:T.114, D:F.199, D:S.200, D:S.200, D:S.200, D:Y.269
- pi-Stacking: D:Y.269, D:Y.269
NAD.10: 9 residues within 4Å:- Chain E: A.32, G.33, M.36, S.37, T.114, G.198, F.199, S.200, Y.269
10 PLIP interactions:10 interactions with chain E- Hydrogen bonds: E:A.32, E:G.33, E:T.114, E:F.199, E:S.200, E:S.200, E:S.200, E:Y.269
- pi-Stacking: E:Y.269, E:Y.269
NAD.12: 9 residues within 4Å:- Chain F: A.32, G.33, M.36, S.37, T.114, G.198, F.199, S.200, Y.269
9 PLIP interactions:9 interactions with chain F- Hydrogen bonds: F:A.32, F:G.33, F:T.114, F:G.198, F:F.199, F:S.200, F:S.200
- pi-Stacking: F:Y.269, F:Y.269
NAD.14: 9 residues within 4Å:- Chain G: A.32, G.33, M.36, S.37, T.114, G.198, F.199, S.200, Y.269
9 PLIP interactions:9 interactions with chain G- Hydrogen bonds: G:A.32, G:G.33, G:T.114, G:G.198, G:F.199, G:S.200, G:S.200
- pi-Stacking: G:Y.269, G:Y.269
NAD.16: 9 residues within 4Å:- Chain H: A.32, G.33, M.36, S.37, T.114, G.198, F.199, S.200, Y.269
10 PLIP interactions:10 interactions with chain H- Hydrogen bonds: H:A.32, H:G.33, H:T.114, H:F.199, H:S.200, H:S.200, H:S.200, H:Y.269
- pi-Stacking: H:Y.269, H:Y.269
NAD.18: 9 residues within 4Å:- Chain I: A.32, G.33, M.36, S.37, T.114, G.198, F.199, S.200, Y.269
10 PLIP interactions:10 interactions with chain I- Hydrogen bonds: I:A.32, I:G.33, I:T.114, I:F.199, I:S.200, I:S.200, I:S.200, I:Y.269
- pi-Stacking: I:Y.269, I:Y.269
NAD.20: 9 residues within 4Å:- Chain J: A.32, G.33, M.36, S.37, T.114, G.198, F.199, S.200, Y.269
9 PLIP interactions:9 interactions with chain J- Hydrogen bonds: J:A.32, J:G.33, J:T.114, J:G.198, J:F.199, J:S.200, J:S.200
- pi-Stacking: J:Y.269, J:Y.269
NAD.22: 9 residues within 4Å:- Chain K: A.32, G.33, M.36, S.37, T.114, G.198, F.199, S.200, Y.269
9 PLIP interactions:9 interactions with chain K- Hydrogen bonds: K:A.32, K:G.33, K:T.114, K:G.198, K:F.199, K:S.200, K:S.200
- pi-Stacking: K:Y.269, K:Y.269
NAD.24: 9 residues within 4Å:- Chain L: A.32, G.33, M.36, S.37, T.114, G.198, F.199, S.200, Y.269
10 PLIP interactions:10 interactions with chain L- Hydrogen bonds: L:A.32, L:G.33, L:T.114, L:F.199, L:S.200, L:S.200, L:S.200, L:Y.269
- pi-Stacking: L:Y.269, L:Y.269
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Tamulaitiene, G. et al., Activation of Thoeris antiviral system via SIR2 effector filament assembly. Nature (2024)
- Release Date
- 2024-02-21
- Peptides
- NAD(+) hydrolase ThsA: ABCDEFGHIJKL
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
HI
IJ
JK
KL
L
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-12-mer
- Ligands
- 12 x OJC: (2R,3R,3aS,5S,6R,7S,8R,11R,13S,15aR)-2-(6-amino-9H-purin-9-yl)-3,6,7,11,13-pentahydroxyoctahydro-2H,5H,11H,13H-5,8-epoxy-11lambda~5~,13lambda~5~-furo[2,3-g][1,3,5,9,2,4]tetraoxadiphosphacyclotetradecine-11,13-dione(Non-covalent)
- 12 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Tamulaitiene, G. et al., Activation of Thoeris antiviral system via SIR2 effector filament assembly. Nature (2024)
- Release Date
- 2024-02-21
- Peptides
- NAD(+) hydrolase ThsA: ABCDEFGHIJKL
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
HI
IJ
JK
KL
L